Skip to main content

Autoimmune Hepatitis: Pathogenesis, Association with Other Syndromes

  • Reference work entry
  • First Online:
Encyclopedia of Medical Immunology

Synonyms

Autoimmune hepatitis

Definition

Autoimmune hepatitis (AIH) is a rare inflammatory liver disease that is clinically characterized by elevations of transaminases (ALT > AST), immunoglobulins, and certain autoantibodies (AAB) as well as exclusion of other relevant causes of hepatitis (e.g., infectious, toxic, vascular, metabolic). Histological hallmarks are the predominantly lymphocytic, mostly plasma cell-rich portal infiltrates with interface hepatitis, although histology alone is never used as diagnosis. A successful treatment with steroids can strengthen the diagnosis of AIH.

Immunopathogenesis

The presence of liver-specific autoantibodies against cytochromes (UDP-glucuronosyltransferases (UGTs) and formiminotransferase cyclodeaminase (FTCD)), the elevation of immunoglobulins, and the dense lymphocytic portal infiltrates suggested an auto-aggressive cellular immune response. This was further supported by successful therapy with immunosuppressants (Kirk et al. 1980; Manns et...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 799.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 949.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Beland K, Lapierre P, et al. Influence of genes, sex, age and environment on the onset of autoimmune hepatitis. World J Gastroenterol. 2009;15(9):1025–34.

    PubMed  CAS  PubMed Central  Google Scholar 

  • Boberg KM, Chapman RW, et al. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol. 2011;54(2):374–85.

    PubMed  Google Scholar 

  • Czaja AJ. Autoantibodies as prognostic markers in autoimmune liver disease. Dig Dis Sci. 2010;55(8):2144–61.

    PubMed  CAS  Google Scholar 

  • Czaja AJ. Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation. Dig Dis Sci. 2012;57(9):2248–66.

    Google Scholar 

  • Efe C, Wahlin S, et al. Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases. Eur J Gastroenterol Hepatol. 2012;24(5):531–4.

    PubMed  Google Scholar 

  • Ferri S, Longhi MS, et al. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology. 2010;52(3):999–1007.

    PubMed  CAS  Google Scholar 

  • Gambineri E, Perroni L, et al.. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. J Allergy Clin Immunol 2008; 122(6): 1105–1112 e1.

    Google Scholar 

  • Greeley SA, Katsumata M, et al. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med. 2002;8(4):399–402.

    PubMed  CAS  Google Scholar 

  • Hardtke-Wolenski M, Noyan F, et al. Requirements and challenges of a preclinical autoimmune hepatitis mouse model. Dig Dis. 2011;29(4):402–10.

    PubMed  Google Scholar 

  • Hardtke-Wolenski M, Fischer K, et al. Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cells. Hepatology 2013; doi: 10.1002/hep.26380.

    Google Scholar 

  • Kirk AP, Jain S, et al. Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis. Gut. 1980;21(1):78–83.

    PubMed  CAS  PubMed Central  Google Scholar 

  • Kisand K, Peterson P. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: known and novel aspects of the syndrome. Ann N Y Acad Sci. 2011;1246:77–91.

    PubMed  CAS  Google Scholar 

  • Lankisch TO, Jaeckel E, et al. The autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy or autoimmune polyglandular syndrome type 1. Semin Liver Dis. 2009;29(3):307–14.

    PubMed  CAS  Google Scholar 

  • Liberal R, Longhi MS, et al. Pathogenesis of autoimmune hepatitis. Best Pract Res Clin Gastroenterol. 2011;25(6):653–64.

    PubMed  CAS  Google Scholar 

  • Liberal R, Grant CR, et al. The impaired immune regulation of autoimmune hepatitis is linked to a defective Galectin-9/Tim-3 pathway. Hepatology. 2012;56(2):677–86.

    PubMed  CAS  Google Scholar 

  • Lleo A, Shimoda S, et al. Primary biliary cirrhosis and autoimmune hepatitis: apotopes and epitopes. J Gastroenterol. 2011;46(Suppl 1):29–38.

    PubMed  CAS  Google Scholar 

  • Longhi MS, Ma Y, et al. Aetiopathogenesis of autoimmune hepatitis. J Autoimmun. 2010a;34(1):7–14.

    PubMed  CAS  Google Scholar 

  • Longhi MS, Ma Y, et al. Adaptive immunity in autoimmune hepatitis. Dig Dis. 2010b;28(1):63–9.

    PubMed  Google Scholar 

  • Manns MP, Woynarowski M, et al. Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. Gastroenterology. 2010;139(4):1198–206.

    PubMed  CAS  Google Scholar 

  • Mix H, Weiler-Normann C, et al. Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis. Gastroenterology. 2008;135(6):2107–18.

    PubMed  CAS  PubMed Central  Google Scholar 

  • Oliveira LC, Porta G, et al. Autoimmune hepatitis, HLA and extended haplotypes. Autoimmun Rev. 2011;10(4):189–93.

    PubMed  CAS  Google Scholar 

  • Oo YH, Hubscher SG, et al. Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management. Hepatol Int. 2010;4(2):475–93.

    PubMed  PubMed Central  Google Scholar 

  • Peiseler M, Sebode M, et al. FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency. J Hepatol. 2012;57(4):933–934.

    CAS  Google Scholar 

  • Sakaguchi S, Miyara M, et al. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol. 2010;10(7):490–500.

    PubMed  CAS  Google Scholar 

  • Selin LK, Cornberg M, et al. CD8 memory T cells: cross-reactivity and heterologous immunity. Semin Immunol. 2004;16(5):335–47.

    PubMed  CAS  Google Scholar 

  • Shevach EM. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity. 2009;30(5):636–45.

    PubMed  CAS  Google Scholar 

  • Strassburg CP, Manns MP. Autoantibodies and autoantigens in autoimmune hepatitis. Semin Liver Dis. 2002;22(4):339–52.

    PubMed  CAS  Google Scholar 

  • Tang J, Zhou C, et al. Association of polymorphisms in non-classic MHC genes with susceptibility to autoimmune hepatitis. Hepatobiliary Pancreat Dis Int. 2012;11(2):125–31.

    PubMed  CAS  Google Scholar 

  • Teufel A, Weinmann A, et al. Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol. 2010;44(3):208–13.

    PubMed  CAS  Google Scholar 

  • Vogel A, Liermann H, et al. Autoimmune regulator AIRE: evidence for genetic differences between autoimmune hepatitis and hepatitis as part of the autoimmune polyglandular syndrome type 1. Hepatology. 2001;33(5):1047–52.

    PubMed  CAS  Google Scholar 

  • Vogel A, Strassburg CP, et al. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology. 2002;35(1):126–31.

    PubMed  CAS  Google Scholar 

  • Wachter B, Kyriatsoulis A, et al. Characterization of liver cytokeratin as a major target antigen of anti-SLA antibodies. Hepatology. 1990;11(2):232–9.

    CAS  Google Scholar 

  • Weiler-Normann C, Wiegard C, et al. A case of difficult-to-treat autoimmune hepatitis successfully managed by TNF-alpha blockade. Am J Gastroenterol. 2009;104(11):2877–8.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael P. Manns .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this entry

Cite this entry

Taubert, R., Jaeckel, E., Manns, M.P. (2014). Autoimmune Hepatitis: Pathogenesis, Association with Other Syndromes. In: Mackay, I.R., Rose, N.R., Diamond, B., Davidson, A. (eds) Encyclopedia of Medical Immunology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-84828-0_195

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-84828-0_195

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-84827-3

  • Online ISBN: 978-0-387-84828-0

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics